<table> 
<tbody>
<tr><th>Rank</th><th>Pathway</th><th>q-value</th></tr>
<tr><td>1</td><td>Immune System</td><td>0.0</td></tr>
<tr><td>2</td><td>Metabolism</td><td>0.0</td></tr>
<tr><td>3</td><td>Metabolism of proteins</td><td>0.0</td></tr>
<tr><td>4</td><td>Signal Transduction</td><td>0.0</td></tr>
<tr><td>5</td><td>Innate Immune System</td><td>0.0005443809623194452</td></tr>
<tr><td>6</td><td>Cell Cycle Checkpoints</td><td>0.007712063632858814</td></tr>
<tr><td>7</td><td>Post-translational protein modification</td><td>0.012929047855086842</td></tr>
<tr><td>8</td><td>Cell Cycle</td><td>0.013026258741215291</td></tr>
<tr><td>9</td><td>MHC class II antigen presentation</td><td>0.015650952666684075</td></tr>
<tr><td>10</td><td>Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein</td><td>0.015772722092466038</td></tr>
<tr><td>11</td><td>TNFR2 non-canonical NF-kB pathway</td><td>0.015819242480304318</td></tr>
<tr><td>12</td><td>Stabilization of p53</td><td>0.01584942489252969</td></tr>
<tr><td>13</td><td>TCR signaling</td><td>0.015887640041605554</td></tr>
<tr><td>14</td><td>FBXL7 down-regulates AURKA during mitotic entry and in early mitosis</td><td>0.015938264841241542</td></tr>
<tr><td>15</td><td>Cytosolic tRNA aminoacylation</td><td>0.015975725399886</td></tr>
<tr><td>16</td><td>Cellular responses to external stimuli</td><td>0.015987451887898005</td></tr>
<tr><td>17</td><td>CDK-mediated phosphorylation and removal of Cdc6</td><td>0.016025908941751026</td></tr>
<tr><td>18</td><td>Extracellular matrix organization</td><td>0.016102054868606074</td></tr>
<tr><td>19</td><td>Ubiquitin-dependent degradation of Cyclin D</td><td>0.016128068165268634</td></tr>
<tr><td>20</td><td>Cellular response to hypoxia</td><td>0.016163063623505187</td></tr>
<tr><td>21</td><td>Regulation of mRNA stability by proteins that bind AU-rich elements</td><td>0.01620770592360168</td></tr>
<tr><td>22</td><td>Asymmetric localization of PCP proteins</td><td>0.016212510698202908</td></tr>
<tr><td>23</td><td>Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins</td><td>0.01626812875768576</td></tr>
<tr><td>24</td><td>Regulation of PTEN stability and activity</td><td>0.016331428869583373</td></tr>
<tr><td>25</td><td>Vif-mediated degradation of APOBEC3G</td><td>0.016358114210873534</td></tr>
<tr><td>26</td><td>Autodegradation of the E3 ubiquitin ligase COP1</td><td>0.016395473688679774</td></tr>
<tr><td>27</td><td>ER-Phagosome pathway</td><td>0.01640433703417972</td></tr>
<tr><td>28</td><td>Regulation of RUNX3 expression and activity</td><td>0.016449203597008244</td></tr>
<tr><td>29</td><td>Vesicle-mediated transport</td><td>0.016468772690352036</td></tr>
<tr><td>30</td><td>APC/C:Cdc20 mediated degradation of mitotic proteins</td><td>0.016471339864572002</td></tr>
<tr><td>31</td><td>Hh mutants that don't undergo autocatalytic processing are degraded by ERAD</td><td>0.01652007573771387</td></tr>
<tr><td>32</td><td>Golgi-to-ER retrograde transport</td><td>0.016539863021822792</td></tr>
<tr><td>33</td><td>C-type lectin receptors (CLRs)</td><td>0.01659000982668511</td></tr>
<tr><td>34</td><td>ABC-family proteins mediated transport</td><td>0.016590657899259304</td></tr>
<tr><td>35</td><td>PCP/CE pathway</td><td>0.01660865991520901</td></tr>
<tr><td>36</td><td>Metabolism of amino acids and derivatives</td><td>0.01662672986329439</td></tr>
<tr><td>37</td><td>Degradation of GLI2 by the proteasome</td><td>0.016653108529135773</td></tr>
<tr><td>38</td><td>Metabolism of RNA</td><td>0.016665697881533905</td></tr>
<tr><td>39</td><td>Dectin-1 mediated noncanonical NF-kB signaling</td><td>0.016759156768548625</td></tr>
<tr><td>40</td><td>Cholesterol biosynthesis</td><td>0.016790545343828678</td></tr>
<tr><td>41</td><td>Cross-presentation of soluble exogenous antigens (endosomes)</td><td>0.016862532247455993</td></tr>
<tr><td>42</td><td>Cdc20:Phospho-APC/C mediated degradation of Cyclin A</td><td>0.016969900368600004</td></tr>
<tr><td>43</td><td>Signaling by Interleukins</td><td>0.01718202412320749</td></tr>
<tr><td>44</td><td>MAPK family signaling cascades</td><td>0.017187511834521208</td></tr>
<tr><td>45</td><td>COPI-dependent Golgi-to-ER retrograde traffic</td><td>0.017189875771702487</td></tr>
<tr><td>46</td><td>Disorders of transmembrane transporters</td><td>0.017213921445218404</td></tr>
<tr><td>47</td><td>Regulation of actin dynamics for phagocytic cup formation</td><td>0.017228180454799513</td></tr>
<tr><td>48</td><td>Cyclin E associated events during G1/S transition</td><td>0.01725301868768322</td></tr>
<tr><td>49</td><td>p53-Independent G1/S DNA damage checkpoint</td><td>0.017305118395683196</td></tr>
<tr><td>50</td><td>RAF/MAP kinase cascade</td><td>0.017314974305706738</td></tr>
</tbody> 
</table>